Verax Biomedical Incorporated

Verax Biomedical manufactures the Platelet PGD prime®, an FDA-cleared rapid diagnostic test for bacterial contamination detection in blood platelets. The test enables extended 7-day platelet dating, addressing FDA guidance on bacterial risk mitigation in blood collection establishments. The platform uses immunoassay technology to detect bacterial cell wall antigens, including enhanced Acinetobacter species detection, providing visual result interpretation without complex sample pretreatment. Designed for blood banks and transfusion services, the test reduces blood product outdate, improves platelet availability, and delivers cost savings through extended dating protocols. The company provides online training and supports FDA compliance for blood safety diagnostics.